中关村(000931.SZ)下属公司盐酸曲唑酮缓释片上市许可申请获受理

智通财经07-15

智通财经APP讯，中关村(000931.SZ)发布公告，公司下属公司北京华素制药股份有限公司于近日收到国家药品监督管理局签发的《受理通知书》，盐酸曲唑酮缓释片(规格：150mg)上市许可申请获得受理。该药品是5-羟色胺(5-HT)受体拮抗剂和5-HT再摄取抑制剂(SARIs)类药物，适用于治疗伴有或不伴有焦虑症状的抑郁症。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2651453258?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-07-15 16:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2651453258","market":"hk","top_or_hot":-1,"title":"中关村(000931.SZ)下属公司盐酸曲唑酮缓释片上市许可申请获受理","media":"智通财经","content":"<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/000931\">中关村</a>(000931.SZ)发布公告，公司下属公司北京华素制药股份有限公司于近日收到国家药品监督管理局签发的《受理通知书》，盐酸曲唑酮缓释片(规格：150mg)上市许可申请获得受理。该药品是5-羟色胺(5-HT)受体拮抗剂和5-HT再摄取抑制剂(SARIs)类药物，适用于治疗伴有或不伴有焦虑症状的抑郁症。</p></body></html>","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>中关村(000931.SZ)下属公司盐酸曲唑酮缓释片上市许可申请获受理</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n中关村(000931.SZ)下属公司盐酸曲唑酮缓释片上市许可申请获受理\n</h2>\n\n<h4 class=\"meta\">\n\n</h4>\n\n</header>\n<article>\n<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/000931\">中关村</a>(000931.SZ)发布公告，公司下属公司北京华素制药股份有限公司于近日收到国家药品监督管理局签发的《受理通知书》，盐酸曲唑酮缓释片(规格：150mg)上市许可申请获得受理。该药品是5-羟色胺(5-HT)受体拮抗剂和5-HT再摄取抑制剂(SARIs)类药物，适用于治疗伴有或不伴有焦虑症状的抑郁症。</p></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"http://www.zhitongcaijing.com/content/detail/1467808.html\">智通财经</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0028","symbol_name":"国家队","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1467808.html","article_id":"2651453258","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2651453258","pubTimestamp":1784104264,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，中关村(000931.SZ)发布公告，公司下属公司北京华素制药股份有限公司于近日收到国家药品监督管理局签发的《受理通知书》，盐酸曲唑酮缓释片(规格：150mg)上市许可申请获得受理。该药品是5-羟色胺(5-HT)受体拮抗剂和5-HT再摄取抑制剂(SARIs)类药物，适用于治疗伴有或不伴有焦虑症状的抑郁症。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK0028":"国家队","BK0239":"医药制造","000931":"中关村","BK0075":"新三板","BK0178":"特色小镇","IPOS":"Renaissance International IPO ETF"},"translate_title":"The marketing authorization application for trazodone hydrochloride sustained-release tablets, a subsidiary of Zhongguancun (000931.SZ), was accepted","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"000931":1.5,"IPOS":1.5},"content_text":"智通财经APP讯，中关村(000931.SZ)发布公告，公司下属公司北京华素制药股份有限公司于近日收到国家药品监督管理局签发的《受理通知书》，盐酸曲唑酮缓释片(规格：150mg)上市许可申请获得受理。该药品是5-羟色胺(5-HT)受体拮抗剂和5-HT再摄取抑制剂(SARIs)类药物，适用于治疗伴有或不伴有焦虑症状的抑郁症。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2651453258","isCrawlerRequest":true}